Recombinant multi-species B3GALNT1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis

Genemedi produces recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine B3GALNT1 protein for cell curture, in vitro study, in vivo study, benchmark, drug discovery & MOA research and positive control for the diagnosis.
This gene is a member of the beta-1,3-galactosyltransferase (beta3GalT) gene family. This family encodes type II membrane-bound glycoproteins with diverse enzymatic functions using different donor substrates (UDP-galactose and UDP-N-acetylglucosamine) and different acceptor sugars (N-acetylglucosamine, galactose, N-acetylgalactosamine). The beta3GalT genes are distantly related to the Drosophila Brainiac gene and have the protein coding sequence contained in a single exon. The beta3GalT proteins also contain conserved sequences not found in the beta4GalT or alpha3GalT proteins. The carbohydrate chains synthesized by these enzymes are designated as type 1, whereas beta4GalT enzymes synthesize type 2 carbohydrate chains. The ratio of type 1:type 2 chains changes during embryogenesis. By sequence similarity, the beta3GalT genes fall into at least two groups: beta3GalT4 and 4 other beta3GalT genes (beta3GalT1-3, beta3GalT5). The encoded protein of this gene does not use N-acetylglucosamine as an acceptor sugar at all. [provided by RefSeq, Mar 2017]
The Alternative Names of target: B3GALNT1,UDP-GalNAc:beta-1,3-N-acetylgalactosaminyltransferase 1,Beta-1,3-GalNAc-T1,Beta-1,3-galactosyltransferase 3 (Beta-1,3-GalTase 3, Beta3Gal-T3, Beta3GalT3, b3Gal-T3), Beta-3-Gx-T3, Galactosylgalactosylglucosylceramide beta-D-acetyl-galactosaminyltransferase, Globoside synthase, UDP-N-acetylgalactosamine:globotriaosylceramide beta-1,3-N-acetylgalactosaminyltransferase,P1,GLOB,GLCT3,galT3,Gb4Cer,beta-1,B3GALT3,b3Gal-T3,3-GalTase,B3GALANT1,3-GalNAc-T1,beta3Gal-T3,beta-3-Gx-T3

Target products collectionGo to B3GALNT1 products collection >>
(antibodies, antigen, VLP, mRNA, ORF viral vector, etc)

pdfMSDSpdfCOApdfDatasheet

Product information

Catalog No. Product Name Species Reactivity
GM-Tg-hg-IP0401-Ab-1/ GM-Tg-hg-IP0401-Ab-2 Human B3GALNT1 protein Human
GM-Tg-rg-IP0401-Ab-1/ GM-Tg-rg-IP0401-Ab-2 Rat B3GALNT1 protein Rat
GM-Tg-mg-IP0401-Ab-1/ GM-Tg-mg-IP0401-Ab-2 Mouse B3GALNT1 protein Mouse
GM-Tg-cynog-IP0401-Ab-1/ GM-Tg-cynog-IP0401-Ab-2 Cynomolgus/Rhesus macaque B3GALNT1 monoclonal antibody Cynomolgus/ Rhesus macaque
GM-Tg-felg-IP0401-Ab-1/ GM-Tg-felg-IP0401-Ab-2 Feline B3GALNT1 protein Feline
GM-Tg-cang-IP0401-Ab-1/ GM-Tg-cang-IP0401-Ab-2 Canine B3GALNT1 protein Canine
GM-Tg-bovg-IP0401-Ab-1/ GM-Tg-bovg-IP0401-Ab-2 Bovine B3GALNT1 protein Bovine
GM-Tg-equg-IP0401-Ab-1/ GM-Tg-equg-IP0401-Ab-2 Equine B3GALNT1 protein Equine

Size： 1mg | 10mg | 100mg



Product Description

Catalog No. GM-Tg-hg-IP0401-Ab-1/ GM-Tg-hg-IP0401-Ab-2; GM-Tg-rg-IP0401-Ab-1/ GM-Tg-rg-IP0401-Ab-2;
GM-Tg-mg-IP0401-Ab-1/ GM-Tg-mg-IP0401-Ab-2; GM-Tg-cynog-IP0401-Ab-1/ GM-Tg-cynog-IP0401-Ab-2;
GM-Tg-felg-IP0401-Ab-1/ GM-Tg-felg-IP0401-Ab-2; GM-Tg-cang-IP0401-Ab-1/ GM-Tg-cang-IP0401-Ab-2;
GM-Tg-bovg-IP0401-Ab-1/ GM-Tg-bovg-IP0401-Ab-2; GM-Tg-equg-IP0401-Ab-1/ GM-Tg-equg-IP0401-Ab-2
Products Name B3GALNT1 protein
Species Human, Cynomolgus/ Rhesus macaque, rat, mouse, Feline, Canine, Bovine, Equine
Target Name B3GALNT1
Protein Sub-location Introcelluar Protein
Isotypes Recombinant protein
Expression platform Mammalian cell
Bioactivity validation Affintiy&bioactivity validated by ELISA, cell culture validated.
Tag His
Products description Recombinant Human, Cynomolgus/ Rhesus macaque, Rat, Mouse, Feline, Canine, Bovine, Equine B3GALNT1 protein was expressed in mammalian cell expression system and is expressed with 6 HIS tag at the C-terminus for cell culture, ELISA or other affinity binding assay or functional assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic).
Purity Purity: ≥95% (SDS-PAGE)
Application In vitro study, in vivo study, benchmark, positive control for the diagnosis. Biological drug disovery including cell culture, assay development, animal model development, PK/PD model development (Pharmacokinetics & Pharmacodynamic) and mechanism of action (MOA) research.
Formulation & Reconstitution Lyophilized from GM's Protein Stability Buffer2 (PSB2,Confidential Ingredients) or PBS (pH7.4);
For PSB2, reconstituted with 0.9% sodium chloride;
For PBS, reconstituted with ddH2O.
Storage Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Reference






    About Gmab

    GDU
    GDU

    GMab, developed by GeneMedi, constitutes an advanced library of recombinant monoclonal antibodies, each meticulously designed to target specific molecular entities. Leveraging the sophisticated capabilities of GM’s Taurus™ and LIBRA™ platforms, GMab synthesizes antibodies characterized by high binding affinity, exceptional physicochemical stability, and optimal developability profiles.
    Through expression in mammalian cell lines, GMab has been established as a paradigmatic reference antibody. It holds significance in myriad domains of biological drug discovery, encompassing cellular cultivation, innovative assay methodologies, strategic animal model systematization, in-depth pharmacokinetic & pharmacodynamic (PK/PD) modeling, and intricate mechanism of action (MOA) investigations.